Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Altered collagen expression in jugular veins in multiple sclerosis.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Mouse hepatitis virus infection upregulates genes involved in innate immune responses.
HERVs in neuropathogenesis.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Regional anesthesia in patients with pre-existing neurologic disease.
Simvastatin affects cell motility and actin cytoskeleton distribution of microglia.
Uses of complementary and alternative medicine in multiple sclerosis.
Ten-year follow-up shows efficacy of Sanofi's MS drug Lemtrada
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
Pages
« first
‹ previous
…
245
246
247
248
249
250
251
252
253
…
next ›
last »